Mostrar el registro sencillo del ítem

dc.contributor.authorMijancos Martínez, Gema
dc.contributor.authorFernández Linsenbarth, Ines 
dc.contributor.authorBachiller Matarranz, Alejandro 
dc.contributor.authorBeño Ruiz De La Sierra, Rosa María 
dc.contributor.authorOsorio Iriarte, María Emma 
dc.contributor.authorRoig Herrero, Alejandro 
dc.contributor.authorRodríguez Valbuena, Claudia
dc.contributor.authorFiorini Talavera, Juan Carlos
dc.contributor.authorRuiz Gómez, Saúl José 
dc.contributor.authorMancha, Ricardo D.
dc.contributor.authorMolina Rodríguez, Vicente 
dc.contributor.authorMañanas, Miguel Ángel
dc.date.accessioned2026-02-03T11:51:22Z
dc.date.available2026-02-03T11:51:22Z
dc.date.issued2026
dc.identifier.citationProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2026, vol. 144, p. 111593es
dc.identifier.issn0278-5846es
dc.identifier.urihttps://uvadoc.uva.es/handle/10324/82486
dc.descriptionProducción Científicaes
dc.description.abstractBackground: EEG recordings associated with transcranial magnetic stimulation (TMS) with paired pulse para- digms allow the in vivo assessment of cortical inhibitory function. The long-interval cortical inhibition (LICI) paradigm can be used to estimate this function related to GABAb receptors. Methods: We compared LICI values between 25 patients with schizophrenia, 16 patients with bipolar disorder (BD), and 23 healthy controls (HC). We also assessed the relationship between LICI values and cognitive per- formance, as well as the treatment with antipsychotics, benzodiazepines, and anticonvulsants. Results: LICI was significantly lower in patients with schizophrenia than in controls, but not in BD patients. In the former group, LICI was negatively associated with cognitive performance and positive symptoms. However, benzodiazepines increased LICI values, which does not explain its decrease in schizophrenia patients. Conclusions: Our data support the existence of a functional inhibitory deficit mediated by GABAb receptors in schizophrenia, that is associated with cognitive performance and symptoms. In the context of existing literature, this deficit may characterize a subgroup of patients with this diagnosises
dc.format.mimetypeapplication/pdfes
dc.language.isoenges
dc.publisherElsevieres
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.classificationLICIes
dc.subject.classificationSchizophreniaes
dc.subject.classificationGABAes
dc.subject.classificationTranscraniales
dc.subject.classificationStimulationes
dc.titleDistinct cortical inhibitory profiles in schizophrenia and bipolar disorder: A TMS-EEG study of GABAb functiones
dc.typeinfo:eu-repo/semantics/articlees
dc.rights.holder© 2026 The Author(s)es
dc.identifier.doi10.1016/j.pnpbp.2025.111593es
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S0278584625003471es
dc.identifier.publicationfirstpage111593es
dc.identifier.publicationtitleProgress in Neuro-Psychopharmacology and Biological Psychiatryes
dc.identifier.publicationvolume144es
dc.peerreviewedSIes
dc.description.projectInstituto de Salud Carlos III (PI-22/00465)es
dc.description.projectJunta de Castilla y León (Gerencia Regional de Salud) (GRS-2685/A1/2023)es
dc.description.projectMinisterio de Ciencia e Innovación - MICIU/AEI /10.13039/501100011033 y por FEDER, UE (grant ID PID2023-150654OB-I00)es
dc.description.projectFundació La Marató de TV3 (ID de subvención 202219-30-31)es
dc.description.projectAgencia de Gestión de Ayudas Universitarias y de Investigación (AGAUR) (subvención FI-2022)es
dc.description.projectMinisterio de Ciencia e Innovación - MCIN/AEI/10.13039/501100011033 y por la Unión Europea NextGenerationEU/PRTR (subvención JDC2022-050016-I)es
dc.rightsAtribución 4.0 Internacional*
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones
dc.subject.unesco32 Ciencias Médicases


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem